
TPX2, ID (TPX2, C20orf1, C20orf2, DIL2, HCA519, gericht eiwit voor Xklp2, Differentiaal uitgedrukt in kankercellen en niet-kankercellen 2, Hepatocellulair carcinoom-geassocieerd antigeen 519, Proteïne fls353, Beperkte expressie proliferatie-associate
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
9007-83-4
[TPX2]
22974
Human
Store product at 4 degree C. DO NOT FREEZE! Stable at 4 degree C for 12 months after receipt as an undiluted liquid. Dilute required amount only prior to immediate use. Further dilutions can be made in assay buffer. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
[TPX2; TPX2; DIL2; p100; DIL-2; HCTP4; FLS353; HCA519; REPP86; C20orf1; C20orf2; GD:C20orf1; C20orf1; C20orf2; DIL2; HCA519; DIL-2; p100]
[TPX2]
[targeting protein for Xklp2; Targeting protein for Xklp2; targeting protein for Xklp2; protein fls353; differentially expressed in lung cells; TPX2, microtubule-associated protein homolog; preferentially expressed in colorectal cancer; hepatocellular carcinoma-associated antigen 519; restricted expression prolif; TPX2, microtubule-associated, homolog (Xenopus laevis); Differentially expressed in cancerous and non-cancerous lung cells 2; DIL-2; Hepatocellular carcinoma-associated antigen 519; Protein fls353; Restricted expression proliferation-associated protein 100]
20127519
NP_036244.2
NM_012112.4
Q9ULW0
Beschrijving
TPX2, ID (TPX2, C20orf1, C20orf2, DIL2, HCA519, gericht eiwit voor Xklp2, Differentiaal uitgedrukt in kankercellen en niet-kankercellen 2, Hepatocellulair carci
Specificaties
Recent bekeken producten

0.22μm Syringe Filter
F1021
13mm, 50 / Pk, 500 / Cs

Erdafitinib
B2458-25
25 mg

TRPM4-IN-2
BA7024-1
1 mg

TRPM4-IN-1
HY-122605-01
5 mg

Anti-RAVV Envelope glycoprotein/GP Recombinant Antibody (SAA2752)
VK160013-01
50 µg

Recombinant BoHV-1 Envelope glycoprotein E
DRA167-01
50 µg

GelRed® Agarose LE
#41029-5G
1x 5 g

50 ml Disposable Serological Pipette
CPP00050
100/CS

